杏昌 (1788.TWO)

142.00 -0.50 (-0.35%) 市場開市。 截至 11:17AM CST。

杏昌

No. 2, Chongxin Road
8F-2 Lane 609, Section 5 Sanchong District
New Taipei City 24159
Taiwan
886 2 2995 3318
https://www.hiclearance.com.tw

版塊: Healthcare
行業: Medical Devices
全職員工: 

描述

Hi-Clearance Inc. supplies medical devices for the renal, cardiac, radiation, dental, oral surgery, and metabolism markets in Taiwan. The company offers dialyzers, dialysis and RO machines, and related consumables and drugs; interventional cardiology and radiology, and vascular surgery devices; dental consumables, implant materials, and equipment; and blood glucose monitors, and related consumables and nutrition products, as well as hemodialysis management services. It engages in the design and management of dialysis centers; and sale and service of healthy and natural drinks, as well as operates as an OEM supplier for beverage raw materials and concentrates. The company was founded in 1989 and is headquartered in New Taipei City, Taiwan.

公司管治

截至 無 止，杏昌 的 ISS 管治質素評分為 無。 Pillar 分數正在審核中：無；董事會：無；股東權利：無；現金賠償：無。

企業管治評分的資料提供： Institutional Shareholder Services (ISS). 評分將以 1 至 10 分顯示 (與指數或地區相關)。1 分表示較低的管治風險，而 10 分表示較高的管治風險。